Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC
Clinical trial NCT04136535 · RECRUITING
Trial details
- NCT number
- NCT04136535
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2026-12-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.